“Precision fermentation is a turning point for sustainable material science,” said Dr. Robin Temmerman, Head of HeiQ Life Sciences. “Through this lab, we are unlocking the power of microorganisms to craft the next generation of actives that combine outstanding performance, purity, and genuine sustainability”.
From research to scalable production
Equipped for microbial strain development, fermentation optimization, and pilot-scale process advancement, the lab bridges discovery to pre-commercial scale-up and validation. It strengthens HeiQ’s partnerships with global leaders in cosmetics, medtech, paper and packaging, feed and animal care, water treatment, and both professional and household cleaning. Many of these partners are already collaborating with HeiQ on synbiotic and microbiome-based technologies.
“Our team translates breakthrough microbial science into real-world impact, delivering scalable, regulatory-ready solutions for healthcare and consumer goods,” added Dr. Ana Bela Torres, Chief Technology Officer of HeiQ Life Sciences.
Strategic investment in Switzerland’s biotech cluster
Located in Schlieren, Zurich, within Switzerland’s vibrant biotech cluster, the lab builds on over three decades of HeiQ’s biotechnology expertise. Its research roadmap includes next-generation postbiotic actives, bacterial cellulose for advanced wound care, textile functionality and packaging reinforcement, and synbiotic formulations that promote balanced microbial ecosystems.
This strategic investment affirms HeiQ’s long-term commitment to replacing conventional materials with sustainable, science-driven alternatives that offer superior performance with lower environmental impact. HeiQ invites partners in healthcare, hygiene, cosmetics, textiles, and environmental sectors to co-develop the next generation of precision-fermented solutions for a more resilient future powered by regenerative biotechnology.
¹ Market Research Future – Precision Fermentation Market Forecast